Sharps Technology Urges Shareholders to Approve the Proposals in connection with the Special Meeting on July 15, 2024
July 03 2024 - 10:55AM
Sharps Technology, Inc. (NASDAQ: “STSS” and “STSSW’) (the
“Company”), an innovative medical device and pharmaceutical
packaging company offering patented, best-in-class syringe
products, encourages its shareholders to participate actively in
the upcoming special meeting of stockholders to be held on July 15,
2024 at 10:00 a.m. eastern time.
The Board of Directors emphasizes the
importance of this shareholders’ vote, specifically so that
the Company can achieve its goal
of passing the three proposals as listed and explained in the
Company’s definitive proxy statement filed on June 26, 2024. The
Company encourages you to vote, even if you no longer own the
shares but were a shareholder of record on the record date of May
17, 2024.
Failure to secure the requisite number of votes
to achieve the Company’s goal of passing these three proposals may
materially impair the Company from executing essential business
matters and may limit the Company’s ability to operate successfully
in the future, while also prohibiting the Company from conducting
important business matters such as: (1) increasing the authorized
number of shares of common stock, if required for future equity
transactions; (2) in its discretion, to effectuate a reverse stock
split of the Company’s common stock, at a ratio of up to 1-for-8,
if required to maintain our Nasdaq listing; and (3) to issue
securities in non-public offerings where the maximum discount will
be equivalent to a discount not to exceed 20% below the market
price of the Company’s common stock.
The passing of the three proposals mentioned
above are extremely important for the Company to continue executing
its business plan. The Board of Directors urges shareholders to
vote in favor of these proposals, as the Board of Directors
believes passing these proposals is in the Company’s best
interest.
How to vote or how to change your
vote:
Shareholders of record as of May 17, 2024, can
vote or change their vote using the instructions in the proxy
materials received via email or mail around June 26, 2024. If you
have not received or located your proxy materials, please contact
your brokerage firm or the Company at (631) 574-4436 or
info@sharpstechnology.com, for your proxy control number.
How do I vote and will my shares be
voted if I do not vote?
If you are a stockholder of record, there are
three ways to vote:
(1) |
|
By Internet at www.proxyvote.com 24 hours a day, seven
days a week, until 11:59 p.m., Eastern Time on July 12, 2024 (have
your 16-digit stockholder control number, which can be found on
your proxy card, in hand when you access the website); |
(2) |
|
By toll-free telephone at 1-800-690-6903, until 11:59 p.m., Eastern
Time on July 12, 2024 (have your 16-digit stockholder control
number, which can be found on your proxy card, in hand when you
call); or |
(3) |
|
Online during the Special Meeting
at www.virtualshareholdermeeting.com/STSS2024SM. You will need
your 16-digit stockholder control number, which can be found on
your proxy card, in hand when you vote online during the Special
Meeting. |
|
|
|
May I change or revoke my
proxy?
If you give us your proxy, you may change or
revoke it at any time before 11:59 p.m., Eastern Time on July 12,
2024. You may change or revoke your proxy in any one of the
following ways:
- if you received a proxy card, by
signing a new proxy card with a date later than your previously
delivered proxy and submitting it as instructed above;
- by re-voting by Internet or by
telephone as instructed above;
- by notifying the Company’s
Secretary in writing before the Special Meeting that you have
revoked your proxy; or
- by attending the Special Meeting
and voting virtually. Attending the Special Meeting virtually will
not in and of itself revoke a previously submitted proxy. You must
specifically request at the Special Meeting that it be
revoked.
Your most current vote, whether by telephone,
Internet or proxy card, is the vote that will be counted.
Your proxy will be voted according to your
instructions. If you are a stockholder of record and do not vote
via the Internet or telephone or by returning a signed proxy card,
your shares will not be voted unless you virtually attend the
Special Meeting and vote your shares online. If you vote via the
Internet or telephone and do not specify contrary voting
instructions, your shares will be voted in accordance with the
recommendations of our Board on all matters, and in the discretion
of proxy holders as to any other matters that may properly come
before the meeting or any adjournment, continuation or postponement
thereof. Similarly, if you sign and submit your proxy card with no
instructions, your shares will be voted in accordance with the
recommendations of our Board on all matters, and in the discretion
of proxy holders as to any other matters that may properly come
before the meeting or any adjournment, continuation or postponement
thereof. We know of no other business to be considered at the
Special Meeting.
Voting will remain open until 11:59 p.m.
ET on July 12, 2024.
We urge you to vote TODAY.
About Sharps Technology
Sharps Technology is an innovative medical
device and pharmaceutical packaging company offering patented,
best-in-class smart-safety syringe products to the healthcare
industry. The Company’s product lines focus on providing ultra-low
waste capabilities, that incorporate syringe technologies that use
both passive and active safety features. Sharps also offers
products that are designed with specialized copolymer technology to
support the prefillable syringe market segment. The Company has a
manufacturing facility in Hungary and is partnering with Nephron
Pharmaceuticals to expand its manufacturing capacity in the U.S.
For additional information, please visit
www.sharpstechnology.com.
Forward-Looking Statements:
This press release contains “forward-looking
statements”. Forward-looking statements reflect our current view
about future events. When used in this press release, the words
“anticipate,” “believe,” “estimate,” “expect,” “future,” “intend,”
“plan,” “poised” or the negative of these terms and similar
expressions, as they relate to us or our management, identify
forward-looking statements. Such statements, include, but are not
limited to, statements contained in this press release relating to
our business strategy, our future operating results and liquidity,
and capital resources outlook. Forward-looking statements are based
on our current expectations and assumptions regarding our business,
the economy, and other future conditions. Because forward–looking
statements relate to the future, they are subject to inherent
uncertainties, risks, and changes in circumstances that are
difficult to predict. Our actual results may differ materially from
those contemplated by the forward-looking statements. They are
neither statements of historical fact nor guarantees of assurance
of future performance. We caution you therefore against relying on
any of these forward-looking statements. Important factors that
could cause actual results to differ materially from those in the
forward-looking statements include, without limitation, our ability
to raise capital to fund continuing operations; our ability to
protect our intellectual property rights; the impact of any
infringement actions or other litigation brought against us;
competition from other providers and products; our ability to
develop and commercialize products and services; changes in
government regulation; our ability to complete capital raising
transactions; and other factors relating to our industry, our
operations and results of operations. Actual results may differ
significantly from those anticipated, believed, estimated,
expected, intended, or planned. Factors or events that could cause
our actual results to differ may emerge from time to time, and it
is not possible for us to predict all of them. We cannot guarantee
future results, levels of activity, performance, or achievements.
The Company assumes no obligation to update any forward-looking
statements in order to reflect any event or circumstance that may
arise after the date of this release.
Contacts:
Sharps Technology, Inc.
Dave GentryRedChip Companies, Inc.1-800-RED-CHIP
(733-2447)Or 407-644-4256STSS@redchip.com
Sharps Technology (NASDAQ:STSS)
Historical Stock Chart
From Jan 2025 to Feb 2025
Sharps Technology (NASDAQ:STSS)
Historical Stock Chart
From Feb 2024 to Feb 2025